Please login to the form below

Not currently logged in
Email:
Password:

Keith Webber leaves FDA for Perrigo

Switches regulatory agency for biopharma company

Perrigo Company has named former US Food and Drug Administration (FDA) employee Keith Webber as head of its regulatory review process.

Perrigo will benefit from Webber's experience working with the US regulator, including most recently as acting director of the office of the FDA's pharmaceutical science in the Center for Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs.

Prior to this, he oversaw regulation of generic medicines at the FDA as director of office of generic drug. This followed a period serving in several other leadership roles within the FDA.

The role marks a switch to the industry side of pharma for Webber, heading all the Perrigo's regulatory activities for both its consumer healthcare and prescription medicine business.

This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.

Perrigo's Chairman, president and CEO Joseph Papa commented that Webber “brings to us a wealth of strategic, scientific and regulatory experience from his years working with the FDA”.

27th September 2013

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics